Walleye Capital LLC Vaxcyte, Inc. Call Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $35,874 - $48,630	600 Added 75.0%	1,400 $95,000
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $36,280 - $50,728	800 New	800 $50,000
Q1 2023 May 15, 2023	SELL	$36.27 - $47.2 $47,151 - $61,360	-1,300 Reduced 50.0%	1,300 $48,000
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $53,507 - $124,670	2,600 New	2,600 $124,000

289

110M

248K

109K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $6.26B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.